China National Accord Medicines Corporation Ltd. (SHE:000028)

SHE:000028 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	12,033	12,773	15,153	14,937	13,164	14,706
Market Cap Growth	-10.74%	-15.71%	1.44%	13.47%	-10.48%	-18.89%
Enterprise Value	13,965	15,631	20,171	20,008	15,577	18,367
Last Close Price	21.02	21.73	25.50	24.75	21.30	23.47

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	11.74	11.24	23.59	9.34	8.85	11.00
Forward PE	10.56	10.36	16.43	10.10	10.14	10.13
PS Ratio	0.16	0.17	0.20	0.20	0.18	0.22
PB Ratio	0.55	0.59	0.73	0.71	0.68	0.82
P/TBV Ratio	0.71	0.77	0.99	1.06	1.03	1.28
P/FCF Ratio	35.34	8.99	5.07	5.71	5.88	11.45
P/OCF Ratio	23.12	7.80	4.63	5.09	5.14	8.89
PEG Ratio	-	0.27	3.29	0.70	0.99	1.13

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.19	0.21	0.27	0.27	0.21	0.27
EV/EBITDA Ratio	5.43	8.09	6.50	5.22	6.13	8.21
EV/EBIT Ratio	8.33	9.09	12.96	8.30	6.78	9.04
EV/FCF Ratio	41.01	11.00	6.75	7.65	6.96	14.30

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.19	0.21	0.28	0.26	0.23	0.27
Debt / EBITDA Ratio	1.59	1.53	1.85	1.40	1.22	1.46
Debt / FCF Ratio	12.03	3.17	1.92	2.06	1.96	3.73
Net Debt / Equity Ratio	-0.05	-0.15	-0.08	-0.05	-0.08	-0.02
Net Debt / EBITDA Ratio	-0.70	-1.70	-0.54	-0.29	-0.64	-0.15
Net Debt / FCF Ratio	-3.18	-2.32	-0.56	-0.43	-0.73	-0.26
Asset Turnover	1.47	1.52	1.56	1.67	1.72	1.66
Inventory Turnover	7.91	8.45	8.60	8.40	8.35	8.68
Quick Ratio	1.21	1.18	1.16	1.11	1.06	1.02
Current Ratio	1.56	1.54	1.52	1.49	1.51	1.42
Return on Equity (ROE)	5.05%	5.33%	1.14%	9.69%	9.46%	8.75%
Return on Assets (ROA)	2.11%	2.23%	2.04%	3.34%	3.36%	3.08%
Return on Invested Capital (ROIC)	6.42%	6.88%	3.29%	10.14%	9.92%	9.65%
Return on Capital Employed (ROCE)	7.20%	7.50%	6.80%	10.40%	10.60%	10.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	9.10%	8.89%	4.24%	10.71%	11.29%	9.09%
FCF Yield	2.83%	11.13%	19.72%	17.51%	17.00%	8.74%
Dividend Yield	2.66%	2.58%	1.31%	2.50%	2.63%	1.79%
Payout Ratio	34.37%	34.01%	93.97%	34.96%	38.62%	45.68%
Buyback Yield / Dilution	0.54%	0.38%	-0.26%	-0.12%	0.00%	-
Total Shareholder Return	3.20%	2.95%	1.05%	2.38%	2.63%	1.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error